ARCHIFAR

This brand name is authorized in Croatia, Cyprus, Malta, Romania, Singapore, Spain, Tunisia.

Active ingredients

The drug ARCHIFAR contains one active pharmaceutical ingredient (API):

1	Meropenem UNII FV9J3JU8B1 - MEROPENEM
	Meropenem exerts its bactericidal activity by inhibiting bacterial cell wall synthesis in Gram-positive and Gram-negative bacteria through binding to penicillin-binding proteins (PBPs).
	Read more about Meropenem

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ARCHIFAR Powder for solution for injection / infusion	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DH02	Meropenem	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DH Carbapenems
Discover more medicines within J01DH02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	83988, 83989
HR	Agencija za lijekove i medicinske proizvode	HR-H-114292639, HR-H-768392975
MT	Medicines Authority	MA032/07903, MA032/07904
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61142001, W61142002, W61142003, W61142004, W61142005, W61143001, W61143002, W61143003, W61143004, W61143005
SG	Health Sciences Authority	14445P, 14844P
TN	Direction de la Pharmacie et du Médicament	6973231H